Burning Rock Biotech Limited

US$13.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BNRHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (37.64%)
Div yield —
ROE (12.82%)
Diagnostics & Research
Beta (5Y) 1.52
PE TTM —
TSR TTM (0.30%)
Mkt cap US$141.5M
ROIC (7.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
13.51%
(82.90%)
Buy 5|0|7|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.13
0.14
0.15
10.05%
11.70%
10.45%
10.62%
Revenue¥M
9.641
9.975
10.16
10.60
9.09%
10.96%
12.72%
14.49%
Peers (US$141.5M)
Cap (US$)
PE
404.9M
94.58x
252.1M
77.04x
140.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.933
0.042
0.038
EBIT/Intx
10.14
0.531
0.402
Own earn%
28.11
126.84
95.34
Sh yield%
23.74
44.24
44.12
Owners
Insiders/Inst%
13.27
81.46
Short interest%
5.71
SBC / revenue%
3.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
22–29
$1 testx
−0.1
Incr. ROIC%
10